Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma

Chang Yi Lu, Sen Yung Hsieh, Yen Jung Lu, Chi Sheng Wu, Lih Chyang Chen, Shao Jung Lo, Cheng Tao Wu, Min Yuan Chou, Hui-ming Huang, Yu Sun Chang

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Investigating aberrant DNA methylation in the cancer genome may identify genes that play an important role in tumor progression. In this study, we combined differential methylation hybridization and a CpG microarray platform to characterize methylation profiles and identify novel candidate genes associated with hepatocellular carcinoma (HCC). The genomic DNA of 21 paired adjacent normal and HCC samples was used, and results were analyzed by hierarchical clustering. Twenty-seven hypermethylated candidates and 38 hypomethylated candidates were obtained. Six candidate genes from the hypermethylated group were validated by combined bisulfite restriction analysis; two genes, human kallikrein 10 gene (KLK10) and oxoglutarate (α-ketoglutarate) receptor 1 gene (OXGR1), were further analyzed by bisulfite sequencing. The DNA hypermethylation status of KLK10 and OXGR1 were subsequently examined in HCC cell lines and clinical samples using methylation-specific PCR. In 49 HCC samples, 46 (94%) showed that at least one of these two genes was highly methylated. Moreover, KLK10 and OXGR1 mRNA levels were inversely correlated (r = -0.435 and -0.497, P < 0.05) with DNA methylation as examined in paired adjacent normal and tumor samples. Statistical analyses further indicated that KLK10 hypermethylation was significantly associated with cirrhosis (P = 0.042) and HCV infection (P = 0.017) as well as inversely associated with HBV infection (P = 0.023). Furthermore, restoration of KLK10 and OXGR1 expression reduced the ability of anchorage-independent growth, and sensitized HCC cells to doxorubicin- or 5-fluorouracil-induced cytotoxicity. Our results suggest that the hypermethylated KLK10 and OXGR1 are frequent in HCC and may be useful as markers for clinical application.

Original languageEnglish (US)
Pages (from-to)1057-1068
Number of pages12
JournalGenes Chromosomes and Cancer
Volume48
Issue number12
DOIs
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Ketoglutaric Acids
Kallikreins
DNA Methylation
Methylation
Hepatocellular Carcinoma
Genes
Neoplasms
DNA
Infection

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Lu, C. Y., Hsieh, S. Y., Lu, Y. J., Wu, C. S., Chen, L. C., Lo, S. J., ... Chang, Y. S. (2009). Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. Genes Chromosomes and Cancer, 48(12), 1057-1068. https://doi.org/10.1002/gcc.20708

Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. / Lu, Chang Yi; Hsieh, Sen Yung; Lu, Yen Jung; Wu, Chi Sheng; Chen, Lih Chyang; Lo, Shao Jung; Wu, Cheng Tao; Chou, Min Yuan; Huang, Hui-ming; Chang, Yu Sun.

In: Genes Chromosomes and Cancer, Vol. 48, No. 12, 12.2009, p. 1057-1068.

Research output: Contribution to journalArticle

Lu, CY, Hsieh, SY, Lu, YJ, Wu, CS, Chen, LC, Lo, SJ, Wu, CT, Chou, MY, Huang, H & Chang, YS 2009, 'Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma', Genes Chromosomes and Cancer, vol. 48, no. 12, pp. 1057-1068. https://doi.org/10.1002/gcc.20708
Lu, Chang Yi ; Hsieh, Sen Yung ; Lu, Yen Jung ; Wu, Chi Sheng ; Chen, Lih Chyang ; Lo, Shao Jung ; Wu, Cheng Tao ; Chou, Min Yuan ; Huang, Hui-ming ; Chang, Yu Sun. / Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma. In: Genes Chromosomes and Cancer. 2009 ; Vol. 48, No. 12. pp. 1057-1068.
@article{40a74eb1bc2244eba82b576b2665ce40,
title = "Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma",
abstract = "Investigating aberrant DNA methylation in the cancer genome may identify genes that play an important role in tumor progression. In this study, we combined differential methylation hybridization and a CpG microarray platform to characterize methylation profiles and identify novel candidate genes associated with hepatocellular carcinoma (HCC). The genomic DNA of 21 paired adjacent normal and HCC samples was used, and results were analyzed by hierarchical clustering. Twenty-seven hypermethylated candidates and 38 hypomethylated candidates were obtained. Six candidate genes from the hypermethylated group were validated by combined bisulfite restriction analysis; two genes, human kallikrein 10 gene (KLK10) and oxoglutarate (α-ketoglutarate) receptor 1 gene (OXGR1), were further analyzed by bisulfite sequencing. The DNA hypermethylation status of KLK10 and OXGR1 were subsequently examined in HCC cell lines and clinical samples using methylation-specific PCR. In 49 HCC samples, 46 (94{\%}) showed that at least one of these two genes was highly methylated. Moreover, KLK10 and OXGR1 mRNA levels were inversely correlated (r = -0.435 and -0.497, P < 0.05) with DNA methylation as examined in paired adjacent normal and tumor samples. Statistical analyses further indicated that KLK10 hypermethylation was significantly associated with cirrhosis (P = 0.042) and HCV infection (P = 0.017) as well as inversely associated with HBV infection (P = 0.023). Furthermore, restoration of KLK10 and OXGR1 expression reduced the ability of anchorage-independent growth, and sensitized HCC cells to doxorubicin- or 5-fluorouracil-induced cytotoxicity. Our results suggest that the hypermethylated KLK10 and OXGR1 are frequent in HCC and may be useful as markers for clinical application.",
author = "Lu, {Chang Yi} and Hsieh, {Sen Yung} and Lu, {Yen Jung} and Wu, {Chi Sheng} and Chen, {Lih Chyang} and Lo, {Shao Jung} and Wu, {Cheng Tao} and Chou, {Min Yuan} and Hui-ming Huang and Chang, {Yu Sun}",
year = "2009",
month = "12",
doi = "10.1002/gcc.20708",
language = "English (US)",
volume = "48",
pages = "1057--1068",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma

AU - Lu, Chang Yi

AU - Hsieh, Sen Yung

AU - Lu, Yen Jung

AU - Wu, Chi Sheng

AU - Chen, Lih Chyang

AU - Lo, Shao Jung

AU - Wu, Cheng Tao

AU - Chou, Min Yuan

AU - Huang, Hui-ming

AU - Chang, Yu Sun

PY - 2009/12

Y1 - 2009/12

N2 - Investigating aberrant DNA methylation in the cancer genome may identify genes that play an important role in tumor progression. In this study, we combined differential methylation hybridization and a CpG microarray platform to characterize methylation profiles and identify novel candidate genes associated with hepatocellular carcinoma (HCC). The genomic DNA of 21 paired adjacent normal and HCC samples was used, and results were analyzed by hierarchical clustering. Twenty-seven hypermethylated candidates and 38 hypomethylated candidates were obtained. Six candidate genes from the hypermethylated group were validated by combined bisulfite restriction analysis; two genes, human kallikrein 10 gene (KLK10) and oxoglutarate (α-ketoglutarate) receptor 1 gene (OXGR1), were further analyzed by bisulfite sequencing. The DNA hypermethylation status of KLK10 and OXGR1 were subsequently examined in HCC cell lines and clinical samples using methylation-specific PCR. In 49 HCC samples, 46 (94%) showed that at least one of these two genes was highly methylated. Moreover, KLK10 and OXGR1 mRNA levels were inversely correlated (r = -0.435 and -0.497, P < 0.05) with DNA methylation as examined in paired adjacent normal and tumor samples. Statistical analyses further indicated that KLK10 hypermethylation was significantly associated with cirrhosis (P = 0.042) and HCV infection (P = 0.017) as well as inversely associated with HBV infection (P = 0.023). Furthermore, restoration of KLK10 and OXGR1 expression reduced the ability of anchorage-independent growth, and sensitized HCC cells to doxorubicin- or 5-fluorouracil-induced cytotoxicity. Our results suggest that the hypermethylated KLK10 and OXGR1 are frequent in HCC and may be useful as markers for clinical application.

AB - Investigating aberrant DNA methylation in the cancer genome may identify genes that play an important role in tumor progression. In this study, we combined differential methylation hybridization and a CpG microarray platform to characterize methylation profiles and identify novel candidate genes associated with hepatocellular carcinoma (HCC). The genomic DNA of 21 paired adjacent normal and HCC samples was used, and results were analyzed by hierarchical clustering. Twenty-seven hypermethylated candidates and 38 hypomethylated candidates were obtained. Six candidate genes from the hypermethylated group were validated by combined bisulfite restriction analysis; two genes, human kallikrein 10 gene (KLK10) and oxoglutarate (α-ketoglutarate) receptor 1 gene (OXGR1), were further analyzed by bisulfite sequencing. The DNA hypermethylation status of KLK10 and OXGR1 were subsequently examined in HCC cell lines and clinical samples using methylation-specific PCR. In 49 HCC samples, 46 (94%) showed that at least one of these two genes was highly methylated. Moreover, KLK10 and OXGR1 mRNA levels were inversely correlated (r = -0.435 and -0.497, P < 0.05) with DNA methylation as examined in paired adjacent normal and tumor samples. Statistical analyses further indicated that KLK10 hypermethylation was significantly associated with cirrhosis (P = 0.042) and HCV infection (P = 0.017) as well as inversely associated with HBV infection (P = 0.023). Furthermore, restoration of KLK10 and OXGR1 expression reduced the ability of anchorage-independent growth, and sensitized HCC cells to doxorubicin- or 5-fluorouracil-induced cytotoxicity. Our results suggest that the hypermethylated KLK10 and OXGR1 are frequent in HCC and may be useful as markers for clinical application.

UR - http://www.scopus.com/inward/record.url?scp=70350236515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350236515&partnerID=8YFLogxK

U2 - 10.1002/gcc.20708

DO - 10.1002/gcc.20708

M3 - Article

C2 - 19760608

AN - SCOPUS:70350236515

VL - 48

SP - 1057

EP - 1068

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 12

ER -